GILEAD SCIENCES, LDA. secures contract for Acquisition Of Sofosbuvir Velpatasvir [400 100 Mg; Treatment 12 Weeks]-Cpa 494/2023

Portugal, July 31 -- Portugal based GILEAD SCIENCES, LDA. has secured contract from Unidade Local De Saude Do Alto Minho, Epe (Ulsam) for Acquisition Of Sofosbuvir Velpatasvir [400 100 Mg; Treatment 12 Weeks]-Cpa 494/2023 . The value of the contract is worth 6530 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....